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Targeted gene disruption studies have established that the c-Jun NH2-terminal kinase (JNK) signaling
pathway is required for stress-induced release of mitochondrial cytochrome c and apoptosis. Here we demon-
strate that activated JNK is sufficient to induce rapid cytochrome c release and apoptosis. However, activated
JNK fails to cause death in cells deficient of members of the Bax subfamily of proapoptotic Bcl2-related
proteins. Furthermore, exposure to stress fails to activate Bax, cause cytochrome c release, and induce death
in JNK-deficient cells. These data demonstrate that proapoptotic members of the Bax protein subfamily are
essential for JNK-dependent apoptosis.
The c-Jun NH2-terminal kinase (JNK) group of mitogen-
activated protein (MAP) kinases is activated when cells are
exposed to environmental stress. Ten members of the JNK
family are created by the alternative splicing of transcripts
derived from the Jnk1, Jnk2, and Jnk3 genes (5). These iso-
forms differ in their substrate specificity in vitro (17). Never-
theless, each JNK isoform can phosphorylate members of the
AP-1 group of transcription factors (c-Jun, JunB, and JunD)
and the AP-1-related transcription factor ATF2 (5). JNK phos-
phorylates these transcription factors within the NH2-terminal
activation domain and increases transcription activity. Indeed,
it is established that JNK regulates AP-1 transcription activity
in vivo and it is likely that increased AP-1 activity mediates, in
part, the effects of the JNK signaling pathway (5).
The physiological function of the JNK signaling pathway is
unclear. However, JNK is required for embryonic viability (24)
and recent studies have demonstrated roles for JNK in multi-
ple physiological processes (60). Thus, JNK can promote cell
survival and JNK is also implicated in some forms of apoptotic
cell death (5). JNK is essential for stress-induced apoptosis,
including neurotrophic factor withdrawal-induced death (10,
63). Studies of Jnk gene disruption in mice have confirmed that
JNK contributes to apoptotic responses. JNK3 is essential for
apoptosis of hippocampal neurons following exposure to exci-
totoxic stress (65). JNK1 and JNK2 are required for thymocyte
apoptosis in response to ligation of the T-cell receptor in vivo
(41, 44, 46). Furthermore, compound disruptions of both the
Jnk1 and Jnk2 genes causes reduced apoptosis in the develop-
ing hindbrain neuroepithelium (24, 45) and primary fibroblasts
isolated from these embryos are resistant to stress-induced
apoptosis (52). Together, these data strongly support a role for
JNK in the apoptotic response.
The mechanism that accounts for the proapoptotic actions
of JNK has not been elucidated. Recent studies have focused
on two different possible mechanisms (5). First, JNK may
cause cell death by regulating the expression of death receptor
ligands (14). For example, a JNK-dependent element in the
Fas ligand promoter that binds c-Jun and ATF2 has been
identified (15). It is therefore possible that JNK may induce
apoptosis by an autocrine or a juxtacrine mechanism involving
the expression of death receptor ligands. A second possible
mechanism was identified in biochemical studies of primary
Jnk1/ Jnk2/ fibroblasts (52). These cells have severe de-
fects in the mitochondrial apoptotic pathway, including the
release of cytochrome c. In contrast, these JNK-deficient cells
exhibited no defect in the apoptotic response to death receptor
signaling. This analysis indicated that JNK may contribute to
the apoptotic response by regulating the intrinsic cell death
pathway involving the mitochondria (52).
The purpose of the study reported here was to examine the
role of JNK in stress-induced apoptosis. Gene knockout stud-
ies indicate that JNK is required for stress-induced apoptosis.
However, it is unclear whether activated JNK is sufficient for
an apoptotic response. Our approach to this question was to
examine the effect of expression of constitutively activated
JNK in cultured cells. The activated JNK caused rapid apo-
ptosis. Analysis of fibroblasts from knockout mice demon-
strated that Bax and the related protein Bak were required for
JNK-stimulated apoptosis. Furthermore, Bax was not activated
by exposure of JNK-deficient fibroblasts to environmental
stress. These data demonstrate that proapoptotic members of
the Bcl2 family are essential for JNK-dependent apoptosis.
MATERIALS AND METHODS
Plasmid construction. Epitope-tagged JNK and MKK7 expression plasmids in
pCDNA3 (Invitrogen Inc.) have been described previously (7, 17, 53, 54). The
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fusion protein expression vectors for MKK7-JNK1 and MKK7-JNK2 were con-
structed by in-frame ligation of JNK11 and JNK22 (T4 polymerase blunt-
ended NruI-HindIII restriction fragments) into the pCDNA3-Flag-MKK2 plas-
mid at the Bsu36 restriction site (blunt-ended with T4 polymerase). The MKK7-
JNK3 vector was constructed by replacing JNK11 in the MKK7-JNK1 vector
with JNK32 (BamHI-SmaI restriction fragments). These fusion proteins en-
code an NH2-terminal epitope tag (Flag), residues 1 to 443 of MKK72 (deletion
of 9 COOH-terminal amino acids), a short linker (His-Glu-Ile-Ser-Arg-Arg-Pro-
Ser-Tyr-Arg-Lys-Gly-Ser), and the complete sequence of JNK11, JNK22, or
JNK32. The fusion protein expression vectors MKK7(KA)-JNK1 and MKK7-
JNK1(APF) were constructed by site-directed mutagenesis to create kinase-
negative MKK7 (Lys149 replaced with Ala) and phosphorylation-negative JNK
(Thr180-Pro-Tyr182 replaced with Ala-Pro-Phe). The fusion protein expression
vector for JNK1-MKK7 was created by in-frame ligation of an MKK72 cDNA
(T4 polymerase blunt-ended BamHI-HindIII restriction fragment) into the
pCDNA3-Flag-JNK12 plasmid at the XbaI restriction site (blunt-ended with T4
polymerase). This fusion protein encodes an NH2-terminal epitope tag (Flag),
residues 1 to 415 of JNK12 (deletion of 11 COOH-terminal amino acids), a
short linker (Gly-Ser-Pro-Gly-Ile-Ser-Gly-Gly-Gly-Gly-Gly-Ile-Leu), and the
complete sequence of MKK72. The plasmid expression vectors for Akt were
obtained from Upstate Biotechnologies, Inc. Bcl2 and tBid expression vectors
(25) were provided by J. Yuan. The Bax cDNA (EcoRI fragment) and the Bak
cDNA (BamHI and EcoRI fragment) were subcloned into the polylinker of
pCDNA3 (Invitrogen) to create mammalian expression vectors for Bax and Bak.
The activated MEK1 expression vector pCMV-HA-N3-MEK1 (S218E, S222D)
(32) was provided by N. Ahn. The activated MKK6 expression vector pCDNA3-
Flag-MKK6 (S207E, T211E) has been described previously (40).
Cell culture. CHO and COS-7 cells were cultured in Ham’s F-12 medium with
5% fetal bovine serum (FBS) and Dulbecco’s modified Eagle’s medium with 5%
FBS, respectively. Mouse embryonic fibroblasts were cultured in Dulbecco’s
modified Eagle’s medium with 10% FBS and 0.1 mM mercaptoethanol. Bax/
Bak/ and Jnk1/ Jnk2/ murine fibroblasts have been described (30, 52).
Bid/ fibroblasts were provided by S. Korsmeyer (67). The culture medium was
supplemented with 2 mM L-glutamine, 100 U of penicillin per ml, and 100 g of
streptomycin per ml. Transfection assays were performed using Lipofectamine in
Opti-MEM I medium (Invitrogen Inc.).
Cell death assays. Cell survival was examined by fluorescence microscopy in
transfection assays using a green fluorescent protein (GFP) reporter plasmid
(pEGFP; Clontech) and a luciferase reporter plasmid (pCDNA3-luciferase [47])
and by crystal violet staining (52). DNA fragmentation was investigated using the
Cell Death Detection ELISAPlus kit (Roche).
Immunofluorescence analysis. Mouse embryonic fibroblasts and CHO cells
were cultured on glass coverslips. The cells were washed three times with ice-cold
phosphate-buffered saline (PBS), fixed with 4% paraformaldehyde in PBS (10
min), permeabilized with 0.2% Triton X-100 in PBS (5 min), and incubated (15
min) in blocking buffer (PBS with 3% [wt/vol] bovine serum albumin and 0.5%
[wt/vol] Tween 20). The coverslips were incubated at room temperature with
primary antibody (anti-cytochrome c or anti-Bax; Pharmingen) in blocking buffer
(30 min), washed three times, and incubated (30 min) with Texas Red-conju-
gated secondary antibody (Jackson ImmunoResearch) at room temperature.
Nuclei were stained with 4,6-diamidino-2-phenylindole (DAPI; Sigma; 1:10,000
dilution). The coverslips were mounted on slides by use of Vectashield (Vector
Labs Inc.) mounting medium. Fluorescence images were examined by conven-
tional microscopy (Zeiss Axioplan).
Microinjection. CHO cells were cultured on gridded coverslips for 2 days and
microinjected with the indicated plasmids together with dog immunoglobulin G
(IgG) or fluorescein-conjugated dextran. The number of apoptotic cells, as de-
termined by cell blebbing and detachment from coverslips, was scored every 15
min after injection. Apoptosis in four independent experiments (at least 150
injected cells) was calculated as the mean percentage  standard deviation (SD)
of total injected cells marked by fluorescein-conjugated dextran. Cytochrome c
release in cells injected with dog IgG was examined after fixing in 3.7% form-
aldehyde and staining with primary antibody (mouse anti-cytochrome c; Pharm-
ingen) and two secondary antibodies (rhodamine-conjugated goat anti-mouse
IgG and fluorescein-conjugated goat anti-dog IgG; Jackson Immunoresearch).
Biochemical analysis. Cells were lysed in Triton X-100 lysis buffer (TLB)
containing 20 mM Tris (pH 7.4), 1% Triton X-100, 10% glycerol, 137 mM NaCl,
2 mM EDTA, 25 mM -glycerophosphate, 1 mM sodium orthovanadate, 1 mM
phenylmethylsulfonyl fluoride, and 10 g of aprotinin and leupeptin per ml.
Immunoblot analysis was performed by probing using antibodies to Flag (Sigma),
hemagglutinin (HA) (Roche), Akt and phospho-Ser473-Akt (Upstate Biotech-
nologies), p38 MAP kinase and phospho-p38 MAP kinase (Promega), ERK and
phospho-ERK (Promega), phospho-JNK (Promega), JNK1/2 (Pharmingen),
JNK3 (Upstate Biotechnologies), MKK7 (Zymed), cytochrome c (Pharmingen),
Bcl2 (Santa Cruz Biotechnology), Bax (Pharmingen), caspase-3 (Santa Cruz
Biotechnology), and activated caspase-3 (48). Immune complexes were detected
by chemiluminescence (NEN Life Science Products). Protein kinase assays were
performed with TLB cell lysates. The protein kinases were immunoprecipitated
using 1 g of anti-Flag M2 antibody prebound to protein G-Sepharose beads
(Sigma). The immunocomplexes were washed three times with TLB and twice
with kinase buffer (25 mM HEPES [pH 7.4], 25 mM -glycerophosphate, 25 mM
MgCl2, 2 mM dithiothreitol, 0.1 mM sodium orthovanadate). The kinase reac-
tion was carried out by incubation at 30°C (20 min) in a final volume of 25 l of
kinase buffer containing 1 g of glutathione S-transferase (GST)–c-Jun and 50
M [	-32P]ATP (10 Ci/nmol). The reaction was terminated by adding Laemmli
sample buffer. The products were resolved on a sodium dodecyl sulfate–12%
polyacrylamide gel and the phosphorylation of GST–c-Jun was detected by
autoradiography and quantitated using a PhosphorImager (Molecular Dynam-
ics).
Luciferase reporter gene assays. Transfection assays using GAL4-ATF2 fusion
proteins were performed using CHO cells (18). CHO cells in 35-mm-diameter
dishes were transfected with 0.125 g of pGal4-ATF2(1-109), 0.25 g of the
luciferase reporter plasmid pG5E1bLuc, and 0.125 g of pRSV -galactosidase
together with 0.4 g of the indicated plasmids. The cells were lysed at 40 h
posttransfection in 1% (vol/vol) Triton X-100, 25 mM glycylglycine (pH 7.8), 15
mM MgSO4, 4 mM EGTA, and 1 mM dithiothreitol. Luciferase and -galacto-
sidase activities in the cell lysates were measured. Relative luciferase activity was
calculated as the luciferase/-galactosidase activity ratio. Assays of AP-1 activity
were performed using the luciferase reporter plasmid 4xTRE (0.5 g) instead of
the pGal4-ATF2 and pG5E1bLuc plasmids.
Statistical analysis. Mean, SD, and Student’s t test calculations were per-
formed using Microsoft Excel 98.
RESULTS
Point mutations that cause JNK activation have not been
identified (5). For example, the replacement of the critical
phosphorylation sites that cause JNK activation with acidic
residues does not cause increased JNK activity. Nevertheless,
activated JNK can be constructed using a fusion protein ap-
proach that was first reported by Cobb and colleagues (42, 69).
This approach involves the fusion of a MAP kinase kinase with
a MAP kinase. Thus, fusion of MEK1 to ERK2 causes consti-
tutive ERK2 activity (42). Gene disruption experiments dem-
onstrate that two MAP kinase kinases (MKK4 and MKK7)
cause JNK activation (51). MKK4 can activate both JNK and
p38 MAP kinase (8, 29). In contrast, MKK7 is a specific acti-
vator of JNK (20, 37, 53, 62, 66). This specificity of MKK7 for
JNK activation suggests that the fusion of MKK7 to JNK may
cause constitutive JNK activation. We therefore prepared a
series of proteins in which different JNK isoforms (JNK11,
JNK22, and JNK32) were fused to one MKK7 isoform
(MKK72). We also prepared two mutant MKK7-JNK fusion
proteins with point mutations that catalytically inactivate
MKK7 (active site Lys149 replaced with Ala) or JNK1 (tripep-
tide dual-phosphorylation motif Thr-Pro-Tyr replaced with
Ala-Pro-Phe). In addition, we constructed a fusion protein
with JNK1 and MKK7 in the reverse orientation. These fusion
proteins are illustrated schematically in Fig. 1A.
To test whether the MKK7-JNK fusion proteins exhibited
constitutive JNK activity, we expressed the fusion proteins in
CHO cells (Fig. 1B). Immunoblot analysis demonstrated that
the amount of JNK, MKK7, and MKK7-JNK fusion proteins
was similar. Immune complex protein kinase assays using the
substrate c-Jun indicated that cotransfection of JNK1 together
with MKK7 caused markedly increased JNK activity compared
with assays with JNK1 alone. Increased kinase activity was also
observed in assays using each of the fusion proteins, including
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MKK7-JNK1 and JNK1-MKK7 (Fig. 1B). These data indicate
that the MKK7-JNK fusion proteins exhibit constitutive JNK
activity. However, we found no evidence that these fusion
proteins caused activation of endogenous JNK in transfection
assays (data not shown). To confirm whether JNK in the fusion
proteins was activated, we performed immunoblot analysis
with an antibody that detects JNK phosphorylated on the trip-
eptide dual-phosphorylation motif Thr-Pro-Tyr. Each of the
fusion proteins was found to contain activated JNK (Fig. 1C).
In contrast, the mutated fusion protein MKK7-JNK1(APF)
was found to lack JNK activity, while the mutated fusion pro-
tein MKK7(KA)-JNK1 exhibited low basal JNK activity (Fig.
1D).
The JNK signaling pathway can regulate AP-1 transcription
activity. We therefore tested the effect of the MKK7-JNK
fusion proteins in cotransfection assays using an AP-1 reporter
plasmid (Fig. 2A). Expression of JNK1 caused no significant
change in AP-1 activity, as expected. In contrast, expression of
MEKK1, a strong activator of the JNK pathway, caused mark-
edly increased AP-1 transcription activity. Similarly, expression
of the MKK7-JNK fusion proteins caused increased AP-1 ac-
tivity. Increased activity was detected in experiments using
JNK1, JNK2, and JNK3 fusion proteins and in experiments
using both MKK7-JNK1 and JNK1-MKK7 fusion proteins.
Interestingly, MEKK1 was unable to increase AP-1 activity in
cells expressing the MKK7-JNK fusion proteins. Together,
these data demonstrate that the constitutively activated JNK
fusion proteins are functional in vivo and cause increased AP-1
FIG. 1. Characterization of MKK7-JNK fusion proteins. (A) Plasmid expression vectors were constructed to express fusion proteins with an
NH2-terminal epitope tag (Flag). The structure of the fusion proteins is schematically illustrated. The MKK7-JNK fusion proteins contain residues
1 to 443 of MKK72 fused to JNK11, JNK22, and JNK32. The JNK1-MKK7 fusion protein contains residues 1 to 415 of JNK12 fused to
MKK72. Point mutations were used to create kinase-negative MKK7 (Lys149 replaced with Ala) and phosphorylation-negative JNK (Thr180-
Pro-Tyr182 replaced with Ala-Pro-Phe). (B) Measurement of JNK protein kinase activity. JNK1, JNK1 plus MKK7, and the MKK7-JNK fusion
proteins were expressed in CHO cells and were detected by immunoblot (IB) analysis using an antibody to the Flag epitope tag (lower panel).
Protein kinase assays were performed using an immune complex assay, with c-Jun and [	-32P]ATP as the substrates. The reaction products were
examined by sodium dodecyl sulfate-polyacrylamide gel electrophoresis. The c-Jun protein was detected by Coomassie staining (middle panel) and
phosphorylated c-Jun was detected by autoradiography (upper panel). The relative kinase activity was quantitated by phosphorimager analysis. The
numbers on the left correspond to the migration of molecular mass standards (in kilodaltons). (C) The activation state of JNK was examined by
immunoblot analysis using an antibody to phospho-JNK. The expression of JNK1, MKK7, and the MKK7-JNK fusion proteins in CHO cell lysates
was examined by immunoblot analysis using an antibody to the Flag epitope tag (lower panel) and to phospho-JNK (upper panel). (D) Comparison
of the wild-type MKK7-JNK1 fusion protein with the catalytically inactive mutant proteins MKK7(KA)-JNK1 and MKK7-JNK1(APF). Upper
panel, the phosphorylation of c-Jun was examined in an in vitro Flag-immune complex protein kinase assay. c-Jun was detected by staining with
Coomassie blue. Phosphorylated c-Jun was detected by autoradiography. Lower panel, the activation state of JNK was examined by immunoblot
analysis by probing with antibodies to the epitope tag (Flag) and phospho-JNK.
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activity (Fig. 2A). Studies of the transcription factor ATF2,
which is phosphorylated and activated by JNK (18, 31), con-
firmed this conclusion (Fig. 2B).
To examine whether the effect of the MKK7-JNK fusion
proteins on transcription activity depends upon increased JNK
activity, we examined the effect of catalytically inactive fusion
proteins on AP-1 activity in luciferase reporter assays (Fig. 2C)
and ATF2 luciferase reporter assays (Fig. 2D). These data
demonstrated that no increased transcription activity was de-
tected in experiments using inactivated JNK (replacement of
the tripeptide dual-phosphorylation motif Thr-Pro-Tyr with
Ala-Pro-Phe) in the fusion protein MKK7-JNK1(APF). Simi-
larly, no increased transcription activity was detected in exper-
iments using inactive MKK7 (replacement of active site Lys149
with Ala) in the fusion protein MKK7(KA)-JNK1. Thus,
catalytically active MKK7 and JNK are required for the fusion
proteins to increase AP-1 activity.
A small increase in AP-1 and ATF2 transcription activity
was observed when the two inactive fusion proteins were co-
expressed [MKK7-JNK1(APF) plus MKK7(KA)-JNK1].
This may be caused by functional complementation between
the two mutated fusion proteins. To test this hypothesis, we
examined JNK activation by immunoblot analysis using an
antibody that binds dually phosphorylated JNK. As expected,
FIG. 2. The MKK7-JNK fusion proteins increase AP-1 transcription activity. (A, C) AP-1 transcription activity was examined in a transfection
assay using a reporter plasmid containing four AP-1 binding sites. CHO cells were cotransfected with the reporter plasmid p4XTRE-luciferase,
a -galactosidase expression vector, and the indicated plasmid expression vectors. The normalized luciferase activity detected in the cell lysates is
presented. The data shown are the means  SD for three independent experiments. (B, D) ATF2 transcription activity was monitored in
transfection assays using a GAL4-ATF2 fusion protein. CHO cells were cotransfected with Gal4-ATF2(1-109), reporter plasmid pG5E1bLuc, a
-galactosidase expression vector, and the indicated plasmids. The normalized luciferase activity detected in the cell lysates is presented. The data
shown are the means  SD for three independent experiments. (E) Immunoblot analysis of transfected CHO cells. Triplicate samples from one
experiment (panel C) were probed with antibody to JNK1/2 (lower panel) and phospho-JNK (upper panel).
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the MKK7-JNK1(APF) fusion proteins did not contain acti-
vated JNK (Fig. 2E), but a low level of activated JNK was
detected in experiments using the MKK7(KA)-JNK1 fusion
protein. In contrast, activated JNK was detected when the two
inactive fusion proteins were coexpressed. These data indicate
partial complementation between the defective functions of
these inactive fusion proteins. The simplest hypothesis is that
MKK7 in the MKK7-JNK1(APF) fusion protein can phos-
phorylate and activate JNK in the MKK7(KA)-JNK1 fusion
protein when these two proteins are coexpressed.
Activated JNK causes cell death. The JNK signal transduc-
tion pathway can contribute to stress-induced apoptosis (5).
However, it is unclear whether activated JNK is sufficient to
induce an apoptotic response. We therefore tested the effect of
activated JNK on the survival of cultured cells (Fig. 3A). In
initial experiments, we cotransfected GFP together with the
inactive fusion protein MKK7-JNK1(APF). Fluorescence mi-
croscopy demonstrated numerous transfected cells expressing
GFP. In contrast, a marked reduction in GFP-positive cells was
detected in cultures transfected with the activated fusion pro-
tein MKK7-JNK1 (Fig. 3A). As a positive control, we demon-
strated that a strong inducer of apoptosis, truncated Bid (tBid),
also caused a marked reduction in the number of GFP-positive
cells. These data indicate that activated JNK can induce cell
death. To confirm this observation, we measured viable cells by
crystal violet staining of the adherent population (Fig. 3B). A
marked reduction in cell viability was detected in cultures
expressing activated JNK1, JNK2, or JNK3 fusion proteins, but
not when these cultures were transfected with wild-type JNK
protein kinases (Fig. 3B). Similar results were obtained in
experiments using an alternative assay of cell viability that
employs a luciferase reporter plasmid (Fig. 3C). Control stud-
ies demonstrated that the inactive fusion proteins MKK7-
JNK1(APF) and MKK7(KA)-JNK1 did not cause marked
cell death (Fig. 3D). However, coexpression of these inactive
fusion proteins did cause some cell death (Fig. 3D), consistent
with the observed partial functional complementation between
these inactive fusion proteins (Fig. 2E).
The cell death caused by activated JNK could be the result
of nonspecific toxicity. To exclude this possibility, we examined
whether the cell death caused by activated JNK could be res-
cued by increased survival signaling. The Akt signaling path-
way is established as an important mediator of cell survival (4).
We therefore examined the effect of overexpression of Akt on
activated JNK-induced cell death. Expression of wild-type Akt
caused no significant reduction in JNK-induced death (Fig.
4A). In contrast, activated Akt (modified by NH2-terminal
myristoylation) caused a marked reduction in activated JNK-
induced cell death (Fig. 4A). These data suggest that the cell
death caused by activated JNK is not the result of nonspecific
toxicity but is the result of increased signal transduction by
JNK.
The observation that activated Akt, but not wild-type Akt,
blocked cell death mediated by activated JNK is interesting
because we had not anticipated that overexpressed wild-type
Akt would not suppress JNK-induced cell death. One possible
explanation is that activated myristoylated Akt has different
signaling properties than wild-type Akt (35). Indeed, we found
that activated JNK caused decreased amounts of activated
wild-type Akt, but not membrane-bound myristoylated and
activated Akt (Fig. 4B). This decrease in the amount of acti-
vated Akt was mediated, in part, by decreased expression of
Akt (Fig. 4B). This observation prompted us to examine other
signaling pathways in cells expressing activated JNK. These
studies demonstrated that the expression of activated JNK did
not cause changes in the activity of endogenous JNK (data not
shown). However, activated JNK did markedly inhibit activa-
tion of the ERK1/2 MAP kinases caused by phorbol ester (data
not shown) and MEK1 (Fig. 5A). In contrast, activated JNK
caused no change in the p38 MAP kinase signaling pathway
(Fig. 5B). The selective effect of activated JNK to suppress
ERK1/2 activation could be mediated by increased expression
of a MAP kinase phosphatase (2). Together, these data dem-
onstrate that activated JNK alters the regulation of Akt and
the ERK-1/2 MAP kinases. Since these signaling pathways
have been implicated in survival signaling by previous studies
(4, 63), it is possible that these changes may contribute to cell
death caused by activated JNK.
Activated JNK causes apoptosis. The cell death caused by
activated JNK could be mediated by several different mecha-
nisms. To test if the cell death was caused by apoptosis, we
examined cells expressing activated JNK for biochemical char-
acteristics of the apoptotic response. The activation of effector
caspases, including caspase-3, is a key step in the apoptotic
program. Expression of activated JNK caused a reduction in
the amount of 32-kDa pro-caspase-3 and a corresponding in-
crease in the amount of processed and activated caspase-3
(Fig. 6A). The activation of caspase-3 was confirmed by prob-
ing immunoblots with an antibody that binds selectively to a
20-kDa processed fragment of caspase-3 (Fig. 6A). These data
indicate that JNK causes caspase activation. One caspase-de-
pendent process in apoptotic cells is nucleosomal fragmenta-
tion of genomic DNA. Indeed, increased nucleosomal DNA
fragmentation was caused by activated JNK1, JNK2, and JNK3
(Fig. 6B). The effects of activated JNK on DNA fragmentation
were blocked by incubation of the cells with the caspase inhib-
itor zVAD-fmk (data not shown).
JNK causes release of mitochondrial cytochrome c by a
caspase-independent mechanism. JNK could activate apopto-
sis by stimulating death receptor signal transduction or by
inducing the intrinsic cell death pathway involving mitochon-
dria. To test the involvement of the intrinsic pathway, we
examined cytochrome c release in cells expressing activated
JNK. The active fusion protein MKK7-JNK1 was sufficient to
induce cytochrome c release and was not inhibited by the
caspase inhibitor zVAD-fmk (Fig. 6C). In contrast, the inactive
fusion protein MKK7-JNK1 (APF) failed to release cyto-
chrome c. These data indicate that JNK causes cytochrome c
release by a caspase-independent mechanism.
JNK causes a rapid apoptotic response. The observation
that activated JNK causes apoptosis in transfection assays does
not provide reliable information concerning the time course of
this effect of JNK. It is possible that JNK causes apoptosis by
an indirect mechanism that requires long periods of JNK ac-
tivation. In contrast, activated JNK may lead to rapid apopto-
sis. To distinguish between these possibilities, we performed
microinjection experiments. The wild-type fusion protein
MKK7-JNK1 caused cytochrome c release (Fig. 7A). Time
course analysis demonstrated that 33% of the microinjected
cells were dead within 3 h postinjection and that 84% of the
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microinjected cells were dead within 4 h (Fig. 7B). No marked
changes in the viability of cells microinjected with the inactive
fusion protein MKK7-JNK1(APF) were detected during this
time period (Fig. 7B). Control studies using a tBid expression
vector demonstrated that this protein caused apoptosis (39%
of cells within 1 h and 88% of cells within 2 h postinjection)
that was more rapid than that caused by activated JNK (data
not shown). The kinetics of tBid-stimulated cytochrome c re-
lease are consistent with the known function of tBid to bind,
induce conformational changes in, and cause mitochondrial
redistribution of Bax and Bak (9, 58). The slightly slower ki-
netics of JNK-stimulated apoptosis may either reflect a lower
expression threshold for the function of tBid or indicate that
several biochemical steps separate JNK activation from the
mechanism of cytochrome c release. Nevertheless, these data
demonstrate that activated JNK does cause rapid apoptosis
and that the observed cell death is not a long-term conse-
quence of JNK activity.
Activated JNK may regulate the function of Bcl2 family
proteins. It has been established in previous studies that JNK
can phosphorylate the antiapoptotic proteins Bcl2 and Bcl-XL
in vitro (6, 13, 23, 34, 64). This phosphorylation has been
reported to inhibit the prosurvival function of Bcl2 and Bcl-XL
(13, 23, 34, 64), although this conclusion is controversial since
some studies indicate that phosphorylation may enhance the
antiapoptotic actions of Bcl2 (6, 22, 43) and may stabilize Bcl2
(and thus increase prosurvival signaling) by preventing ubiq-
uitin-mediated degradation of Bcl2 (3, 11). Taken together,
FIG. 3. Activated JNK causes cell death. (A) CHO cells were co-
transfected with a GFP expression vector together with expression
vectors for the MKK7-JNK1 fusion protein (wild type and phosphor-
ylation defective) or an active fragment of the BH3-only protein Bid
(tBid). The cells were examined at 40 h posttransfection by fluores-
cence microscopy. The data presented are representative of three
independent experiments. (B) CHO cells were transfected with empty
vector or with the indicated expression plasmids. The cells were har-
vested after 40 h and stained with crystal violet. The data shown are the
means  SD for three independent experiments. (C, D) CHO cells
were cotransfected with the indicated expression vectors and a lucif-
erase expression vector (pCDNA3-Luc) to monitor cell viability. The
cells were harvested at 40 h posttransfection and luciferase activity was
measured. The data shown are the means  SD for three independent
experiments.
FIG. 4. JNK-stimulated apoptosis is inhibited by Akt. (A) CHO
cells were transfected with vector control, Akt, or activated Akt (myr-
istoylated Akt) together with the indicated plasmid expression vectors.
Decreased cell survival caused by activated JNK (MKK7-JNK) was
prevented by activated Akt. (B) The cell lysates were examined by
immunoblot analysis using antibodies to Akt and phospho-Ser473-Akt.
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these data indicate that Bcl2 and Bcl-XL represent potential
sites of regulation by JNK, although the exact role of JNK-
regulated phosphorylation of these proteins is unclear.
We examined Bcl2 phosphorylation in cells expressing the
activated JNK fusion proteins. Immunoblot analysis demon-
strated that the MKK7-JNK1 fusion protein caused a marked
decrease in the electrophoretic mobility of Bcl2, consistent
with phosphorylation (Fig. 8A). However, only a fraction of the
Bcl2 was found to become phosphorylated in cells overexpress-
ing MKK7-JNK1 (Fig. 8A). This partial phosphorylation of
Bcl2 was unexpected because previous studies have suggested
that Bcl2 is a JNK substrate and we had expected that the
overexpression of activated JNK would lead to stoichiometric
phosphorylation of Bcl2. To examine further the extent of Bcl2
phosphorylation caused by activated JNK, we investigated the
effect of changes in the expression of Bcl2. These studies dem-
onstrated that Bcl2 phosphorylation was only observed when
Bcl2 was expressed at a low level (Fig. 8B). Interestingly, ex-
pression of Bcl2 partially inhibited apoptosis caused by the
MKK7-JNK1 fusion protein (Fig. 8C).
The observation that only a fraction of the total population
of Bcl2 molecules can be phosphorylated in cells with activated
JNK is interesting. Whether this partial phosphorylation of
Bcl2 is sufficient to account for the ability of activated JNK to
cause apoptosis is unclear. If this phosphorylation does cause
reduced antiapoptotic signaling (13, 23, 34, 64), it is possible
that the partial phosphorylation decreases Bcl2 function below
a threshold that is required to maintain survival. In contrast, if
Bcl2 phosphorylation causes increased antiapoptotic signaling
(3, 6, 11), it is not obvious how the partial Bcl2 phosphorylation
might contribute to JNK-stimulated apoptosis.
In addition to the antiapoptotic protein Bcl2, previous stud-
ies have also implicated the proapoptotic BH3-only protein
Bid in JNK-stimulated apoptosis (52). It was observed that UV
radiation caused Bid cleavage by a caspase-independent mech-
anism and that this processing of Bid was absent in Jnk-null
cells (52). These data suggested that Bid might contribute to
JNK-stimulated apoptosis. To test this hypothesis, we exam-
ined the effect of activated JNK on wild-type and Bid/ fi-
broblasts (Fig. 9A). The MKK7-JNK1 fusion protein efficiently
FIG. 5. Activated JNK causes decreased ERK activity. (A) CHO cells were transfected with an empty expression vector (control) or with an
expression vector for activated MEK1 (HA-N3-MEK1 [S218E, S222D]) together with the indicated expression vectors. The cells were harvested
at 40 h posttransfection. Endogenous ERK1 and ERK2 were examined by immunoblot analysis using an antibody to ERK and phospho-ERK. The
expression of transfected MEK1 was examined by immunoblot analysis using an antibody to the HA epitope tag. (B) Activated JNK does not cause
decreased p38 MAP kinase activity. CHO cells were transfected with an empty expression vector (control) or with an expression vector for activated
MKK6 (Flag-MKK6 [S207E, T211E]) together with the indicated expression vectors. The cells were harvested at 40 h posttransfection. Endog-
enous p38 MAP kinase was examined by immunoblot analysis using an antibody to p38 and phospho-p38.
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killed the Bid/ cells (Fig. 9A). Control studies demonstrated
that Jnk-null cells were also efficiently killed by the MKK7-
JNK1 fusion protein (Fig. 9B). In contrast, the kinase-inactive
mutant fusion protein MKK7-JNK1(APF) did not cause apo-
ptosis of wild-type, Jnk-null, or Bid/ cells. These data dem-
onstrate that Bid does not play an essential role in JNK-de-
pendent apoptosis.
The observation that JNK activation does regulate Bcl2
phosphorylation (Fig. 8A) and Bid processing (52) suggests
that Bcl2 family proteins may contribute to JNK-stimulated
apoptosis. However, Bid is not required for JNK-dependent
apoptosis and the importance of Bcl2 phosphorylation is un-
clear (Fig. 8 and 9). These considerations suggest that other
members of the Bcl2 family may contribute to JNK-dependent
apoptosis. Other members of the Bcl2 family that are poten-
tially relevant include the proapoptotic proteins Bax and Bak.
Bax and Bak are required for JNK-dependent apoptosis.
Members of the proapoptotic Bax subfamily of Bcl2-like pro-
teins represent potential targets of the JNK-dependent apo-
ptosis signaling pathway (36). Recent studies indicate redun-
dant functions of Bax and the related protein Bak (30).
FIG. 6. Activated JNK causes apoptosis. (A) Cell lysates prepared
at 40 h posttransfection were examined by immunoblot analysis using
antibodies to the Flag epitope tag (lower panel), activated caspase-3
(middle panel), and caspase-3 (upper panel). Equal amounts of total
cell lysate (50 g) were examined in each lane. The effect of exposure
of the cells to UV radiation (80 J/m2) 12 h prior to harvesting was
examined. The numbers on the left correspond to the migration of
molecular mass standards (in kilodaltons). (B) CHO cells were trans-
fected with empty vector (control) or the indicated expression vectors.
Nucleosomal DNA fragmentation was examined at 40 h posttransfec-
tion. The data presented are the means  SD of the results obtained
for three independent experiments. (C) Activated JNK causes cyto-
chrome c release from the mitochondria. CHO cells were cotrans-
fected with GFP and the indicated expression vectors. The cells were
fixed after 24 h, processed for immunofluorescence analysis, and
stained with DAPI. GFP (green), DNA (blue), and cytochrome c (red)
are illustrated. The cells were incubated with 100 M zVAD-fmk to
inhibit apoptosis. Transfected cells (green) show punctate mitochon-
drial cytochrome c (red) in experiments using the kinase-negative
fusion protein MKK7-JNK1(APF). Expression of tBid or MKK7-
JNK1 caused the release of cytochrome c from the mitochondria and
the redistribution of cytochrome c throughout the cytoplasm and nu-
cleus.
FIG. 7. JNK causes rapid release of cytochrome c and apoptosis.
(A) Activated JNK causes cytochrome c release from the mitochon-
dria. CHO cells were microinjected with the MKK7-JNK1 expression
plasmid together with dog IgG. The injected cells were visualized by
staining with fluorescein-conjugated anti-dog IgG (green, indicated by
arrowheads) and cytochrome c was stained with mouse anti-cyto-
chrome c and rhodamine-conjugated goat anti-mouse antibodies. Cells
releasing cytochrome c showed diffuse cytoplasmic and nuclear stain-
ing (red). Punctate mitochondrial staining was observed in the nonin-
jected cells. (B) Time course of apoptosis induced by microinjection of
MKK7-JNK1. CHO cells were microinjected with the indicated plas-
mids and apoptosis was evaluated by membrane blebbing and cell
detachment. The data presented represent the means  SD of data
obtained for four independent experiments.
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Fibroblasts with compound mutations in both the Bax and Bak
genes are remarkably resistant to stress-induced cytochrome c
release and apoptosis (59, 70). This phenotype is similar to
JNK-deficient primary fibroblasts (52). Thus, Bax and Bak may
be required for JNK-dependent apoptosis. To test this hypoth-
esis, we examined fibroblasts derived from wild-type and
Bax/ Bak/ mice (Fig. 10A). Expression of activated JNK
caused apoptosis of wild-type fibroblasts. In contrast, the
Bax/ Bak/ fibroblasts were resistant to the apoptotic ef-
fects of activated JNK (Fig. 10A). Together, these data dem-
onstrate that the proapoptotic proteins Bax and Bak are es-
sential for JNK-dependent apoptosis.
The defect in JNK-stimulated apoptosis observed in Bax/
Bak/ fibroblasts (Fig. 10A) suggests that Bax and Bak may
act as downstream components of a JNK-stimulated apoptotic
signaling pathway. If this mechanism is correct, it would be
predicted that Jnk-null cells would not be resistant to the pro-
apoptotic effects of Bax and Bak. Control studies demon-
FIG. 8. Regulation of Bcl2 by activated JNK. (A) Activated JNK
causes Bcl2 phosphorylation in vivo. CHO cells were transfected with-
out and with a plasmid expression vector for human Bcl2 (20 ng). The
cells were cotransfected with the empty expression vector or expression
vectors for JNK1 and MKK7-JNK1 fusion proteins. The cells were
harvested at 40 h posttransfection and the expression of Bcl2 was
examined by immunoblot analysis. (B) Bcl2 phosphorylation is sup-
pressed by increased expression of Bcl2. CHO cells were cotransfected
with an expression vector for the Flag-MKK7-JNK1 fusion protein
together with increasing amounts of an expression vector for human
Bcl2 (0, 10, 20, 40, 60, and 80 ng). The cells were harvested at 40 h
posttransfection and the expression of Bcl2 and Flag-MKK7-JNK1 was
examined by immunoblot analysis. (C) CHO cells were transfected
with an empty vector (control) or an expression vector for the MKK7-
JNK1 fusion protein. The effect of expression of Bcl2 was examined
(20 ng of plasmid). Cell viability at 40 h posttransfection was examined
using a luciferase reporter plasmid. The data presented represent the
means  SD of data obtained for three independent experiments.
FIG. 9. The proapoptotic Bcl2 family protein Bid is not required
for JNK-dependent apoptosis. (A) Bid is not required for JNK-depen-
dent apoptosis. Wild-type and Bid/ mouse fibroblasts were trans-
fected with empty vector (control) or expression vectors for MKK7-
JNK fusion proteins. Cell viability at 40 h posttransfection was
examined using a luciferase reporter plasmid. The data presented
represent the means  SD of data obtained for three independent
experiments. (B) Endogenous JNK is not required for apoptosis
caused by ectopic expression of activated JNK. Wild-type and Jnk1/
Jnk2/ mouse fibroblasts were transfected with empty vector (con-
trol) or expression vectors for MKK7-JNK fusion proteins. Cell via-
bility at 40 h posttransfection was examined using a luciferase reporter
plasmid. The data presented represent the means  SD of data ob-
tained for three independent experiments.
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strated that the BH3-only protein tBid caused apoptosis of
wild-type and Jnk-null cells (Fig. 10B). Similarly, the expres-
sion of Bax or Bak also caused apoptosis of wild-type and
Jnk-null cells (Fig. 10B). These data are consistent with the
hypothesis that Bax and Bak function as downstream compo-
nents of a JNK-stimulated apoptosis signaling pathway.
JNK is required for the stress-induced activation of Bax.
The requirement of Bax and Bak for JNK-dependent apoptosis
(Fig. 10A) suggests that JNK deficiency may cause a defect in
the normal function of Bax or Bak. To test this hypothesis, we
examined the effect of UV radiation on Bax activation using a
conformation-specific monoclonal antibody that binds acti-
FIG. 10. The proapoptotic Bcl2 family proteins Bax and Bak are required for JNK-dependent apoptosis. (A) Bax and Bak are required for
JNK-dependent apoptosis. Wild-type and Bax/ Bak/ mouse fibroblasts were transfected with empty vector (control) or expression vectors for
JNK1 or MKK7-JNK fusion proteins. Cell viability at 40 h posttransfection was examined using a luciferase reporter plasmid. The data presented
represent the means  SD of data obtained for three independent experiments. (B) Endogenous JNK is not required for apoptosis caused by Bax
and Bak. Wild-type and Jnk1/ Jnk2/ mouse fibroblasts were transfected with empty vector (control) or expression vectors for Bax, Bak, or tBid.
Cell viability at 40 h posttransfection was examined using a luciferase reporter plasmid. The data presented represent the means  SD of data
obtained for three independent experiments. (C) Bax is not activated by UV radiation in JNK-deficient murine fibroblasts. Wild-type and Jnk1/
Jnk2/ fibroblasts were exposed to UV radiation (80 J/m2) and incubated (24 h). The cells were fixed and stained with a conformation-specific
antibody to Bax and Texas Red-conjugated goat anti-mouse antibody. The Bax antibody stains activated and membrane-targeted Bax but not
cytoplasmic Bax. DNA was stained with DAPI (blue).
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vated Bax (21). Immunofluorescence microscopy demon-
strated that UV radiation caused Bax activation in wild-type
fibroblasts but not in JNK-deficient (Jnk1/ Jnk2/) fibro-
blasts (Fig. 10C). Control studies using immunoblot analysis
demonstrated that the wild-type and JNK-deficient fibroblasts
expressed similar amounts of Bax (52). Together, these data
demonstrate that Bax activation is JNK dependent in cells
exposed to stress.
The defective Bax activation in JNK-deficient cells exposed
to stress (Fig. 10C) might reflect a specific role of JNK in the
response of cells to particular stimuli, or it might reflect a
general requirement of JNK for Bax function. To distinguish
between these possibilities, we examined the effect of the BH3-
only protein tBid, which is known to induce Bax and Bak
oligomerization and insertion into the mitochondrial outer
membrane (9, 58, 59, 70). The effects of tBid on cytochrome c
release and apoptosis require Bax and Bak (58, 59, 70). Mi-
croinjection experiments demonstrated that tBid caused effi-
cient cytochrome c release and apoptosis in both wild-type and
JNK-deficient (Jnk1/ Jnk2/) fibroblasts (data not shown).
Furthermore, transfection assays confirmed that tBid can kill
Jnk-null cells (Fig. 10B). Thus, JNK is required for Bax and
Bak activation caused by exposure of cells to stress (Fig. 10C)
but is not required for cell death initiated by BH3-only proteins
(Fig. 10B). Together, these data indicate that BH3-only mem-
bers of the Bcl2 family may function downstream of JNK and
upstream of Bax and Bak in a stress-induced apoptotic signal-
ing pathway.
DISCUSSION
Activated JNK causes cell death. Expression of activated
JNK in cultured cells leads to rapid cell death (Fig. 7). Time
course measurements in cells microinjected with a plasmid
expression vector demonstrated that most of the cells died
within 4 h. The cell death observed was inhibited by the broad-
spectrum caspase inhibitor zVAD-fmk, indicating that the
JNK-stimulated cell death was apoptosis. Indeed, several char-
acteristics of apoptosis were detected in cells expressing acti-
vated JNK, including membrane blebbing, chromatin conden-
sation, DNA fragmentation, and activation of caspase-3 (Fig. 6
and 7). Together, these data demonstrate that activated JNK
can be sufficient for apoptosis. This conclusion complements
the results of previous studies that indicate a requirement of
JNK for some forms of stress-induced apoptosis (52, 63).
Interestingly, the expression of activated Akt, a kinase that is
known to promote cell survival (4), inhibited apoptosis caused
by activated JNK (Fig. 4A). Furthermore, the JNK-stimulated
apoptosis was suppressed by coexpression of the antiapoptotic
protein Bcl2 (Fig. 8C). Since JNK-stimulated apoptosis can be
suppressed by increased survival signaling, the decision to die
in response to JNK activation in vivo will depend upon multi-
ple factors, including the cytokine environment, and may be
cell-type specific.
Activated JNK regulates the mitochondrial apoptotic path-
way. It is established that JNK is essential for some forms of
stress-induced apoptosis (5). Studies of primary embryo fibro-
blasts isolated from mice with compound disruptions of the Jnk
genes indicate that JNK is required for apoptosis in response
to environmental stress but not in response to death receptor
ligands (52). Biochemical studies demonstrate that these JNK-
deficient cells exhibit defects in the mitochondrial apoptotic
pathway. Several apoptotic molecules have been shown to be
released from mitochondria. These include the flavoprotein
AIF, which causes chromosomal DNA condensation and frag-
mentation (49); endonuclease G, which degrades chromo-
somal DNA (27, 38); Smac/Diablo, which antagonizes the ac-
tions of IAP molecules (12, 56); the protease Omi/HtrA2,
which also antagonizes IAP function (19, 33, 50, 55, 57); and
cytochrome c, which activates the Apaf-1/caspase-9 complex
(26, 28). JNK-deficient primary embryo fibroblasts fail to re-
lease mitochondrial proapoptotic molecules in response to en-
vironmental stress (52). In this study, we demonstrate that the
expression of activated JNK in cultured cells causes the release
of mitochondrial cytochrome c (Fig. 6 and 7). This effect of
activated JNK was not reduced by the broad-spectrum caspase
inhibitor zVAD-fmk. Thus, JNK-induced activation of the mi-
tochondrial apoptosis pathway is not a secondary consequence
of caspase activation. Indeed, biochemical studies have dem-
onstrated that JNK can cause the release of cytochrome c in
vitro (1). Together, these data establish that JNK is both nec-
essary and sufficient for activation of the intrinsic cell death
pathway involving the mitochondria in response to environ-
mental stresses, including UV radiation.
Members of the Bcl2 group of apoptotic regulatory proteins
may contribute to signaling by JNK. Three subfamilies of Bcl2
proteins have been identified to play important roles in the
apoptotic response. The Bcl2 subfamily (e.g., Bcl2 and Bcl-XL)
functions to inhibit apoptosis, while the Bax subfamily (e.g.,
Bax, Bak, Bok, and Bcl-XS) and the BH3-only subfamily (Bid,
Bad, Bik, Bim, Bmf, Noxa, Puma, and a number of others)
promote apoptosis (16). Recently, these Bcl2 family proteins
have been implicated in JNK-dependent apoptosis (5).
The antiapoptotic proteins Bcl2 and Bcl-XL have been re-
ported to be phosphorylated and inactivated by JNK (6, 13, 23,
34, 64), although this conclusion is controversial since some
studies indicate that phosphorylation may enhance the anti-
apoptotic actions of Bcl2 (6, 22, 43) and may stabilize Bcl2
(and thus increase prosurvival signaling) by preventing ubiq-
uitin-mediated degradation of Bcl2 (3, 11). Taken together,
these data indicate that Bcl2 and Bcl-XL represent potential
sites of regulation by JNK. Consistent with this hypothesis, we
found that the expression of activated JNK in cultured cells
caused increased Bcl2 phosphorylation (Fig. 8A). It is possible
that Bcl2 phosphorylation mediates, in part, the effects of JNK
on apoptosis. If Bcl2 phosphorylation inhibits prosurvival sig-
naling (6, 13, 23, 34, 64), the phosphorylation of Bcl2 may
decrease the level of functional Bcl2 below a threshold that is
required for cell survival. Alternatively, if phosphorylation of
Bcl2 increases cell survival signaling (3, 6, 11, 22, 43), the role
of Bcl2 phosphorylation in JNK-stimulated apoptosis is un-
clear.
It is interesting that the overexpression of activated JNK
leads only to partial phosphorylation of Bcl2 (Fig. 8A). Fur-
thermore, it is intriguing that this phosphorylation of Bcl2 is
only observed at low levels of Bcl2 expression (Fig. 8B). At
higher levels of Bcl2 expression, JNK-stimulated apoptosis is
inhibited (Fig. 8C) and Bcl2 is not phosphorylated (Fig. 8B).
These data suggest that Bcl2 phosphorylation correlates with
apoptosis rather than with JNK activation. Consistent with this
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hypothesis are previous studies that demonstrate that JNK
activation caused by UV radiation does not result in Bcl2
phosphorylation (51). Furthermore, Bcl2 phosphorylation
caused by paclitaxel (Taxol) occurs in the absence of JNK
activation (51). Together, these data indicate that JNK may not
be the physiologically relevant kinase that causes Bcl2 phos-
phorylation in vivo. In contrast, it appears that activated JNK
may regulate another kinase (or a phosphatase) that causes
increased Bcl2 phosphorylation.
Several studies have implicated BH3-only members of the
Bcl2-related family in JNK-dependent apoptosis. JNK-defi-
cient fibroblasts were reported to exhibit defects in the UV-
stimulated, caspase-independent processing and activation of
Bid (52). However, studies of Bid/ fibroblasts do not support
a (nonredundant) role for Bid in JNK-dependent apoptosis
(Fig. 9A). Furthermore, microinjection studies demonstrated
that tBid, which is myristoylated and targeted to the mitochon-
dria (68), efficiently killed both wild-type and JNK-deficient
fibroblasts (Fig. 10B). These data demonstrate that JNK is not
required for Bid-stimulated apoptosis and that Bid is not es-
sential for JNK-stimulated apoptosis. However, other mem-
bers of the BH3-only subfamily may be required for JNK-
dependent apoptosis. Indeed, a recent study indicates that the
expression of the proapoptotic BH3-only protein Bim may be
JNK dependent (61), although an independent study indicates
that JNK is not required for Bim expression but may be re-
quired for Bim function (39).
While the role of Bcl2 and Bcl-XL phosphorylation and
BH3-only proteins in JNK-dependent apoptosis remains un-
clear, the results of the present study establish that the pro-
apoptotic Bax subfamily of Bcl2-related proteins is essential
for JNK-dependent apoptosis.
The Bax subfamily of Bcl2-related proteins is essential for
JNK-induced apoptosis. Members of the proapoptotic Bax
subfamily of Bcl2-related proteins, including Bax and Bak, are
cytoplasmic proteins that undergo a conformational change in
response to environmental stress and redistribute to the mito-
chondria (16). It is likely that Bax (and related members of this
subfamily) mediates the release of proapoptotic molecules
from the mitochondria. Interestingly, the mitochondrial redis-
tribution of, and conformational changes in, Bax are not ob-
served in JNK-deficient cells exposed to stress (Fig. 10C). This
observation suggests that members of the Bax subfamily may
mediate the effects of JNK on apoptosis. The functions of Bax
are partially redundant with those of the related molecule Bak
(30). Consequently, studies of Bax deficiency require the anal-
ysis of compound mutations of Bax and Bak. Interestingly,
Bax/ Bak/ embryo fibroblasts exhibit defects in stress-
induced apoptosis (59) that are similar to those in JNK-defi-
cient fibroblasts (52). Furthermore, Bax/ Bak/ fibroblasts
are resistant to the apoptotic effects of activated JNK (Fig.
10A).
The results of the present study demonstrate that JNK is
required for stress-induced activation of Bax (Fig. 10C). In
addition, Bax is essential for JNK-stimulated apoptosis (Fig.
10A). These data are consistent with the hypothesis that mem-
bers of the proapoptotic Bax subfamily of Bcl2-related proteins
function downstream of JNK in an apoptotic signal transduc-
tion pathway that is initiated by stress.
A goal for future studies will be to define the mechanism by
which JNK regulates Bax and Bak. It is established that BH3-
only members of the Bcl2 family can engage Bax and Bak to
release mitochondrial cytochrome c (9, 58, 59). Gene knockout
studies have confirmed this conclusion (70). These consider-
ations suggest that the effects of JNK to activate the mitochon-
drial apoptotic signaling pathway via Bax and Bak may be
mediated by increased expression or function of one or more
BH3-only proteins.
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